Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.42B 4.01B 511M 459M 429M 388M 729M 48.61B 734M 5.14B 2.01B 25.23B 1.92B 1.88B 81.14B P/E 2026 *
7.52x
P/E 2027 * 6.68x
Enterprise Value 3.42B 4.01B 511M 459M 429M 388M 729M 48.61B 734M 5.14B 2.01B 25.23B 1.92B 1.88B 81.14B EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.45x
Free-Float
45.7%
Yield 2026 *
5.99%
Yield 2027 * 6.74%
08-28 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day+1.62%
1 week+1.95%
Current month+0.32%
1 month-0.32%
3 months-6.57%
6 months-19.33%
Current year-29.02%
1 week 3
Extreme 3
3.2
1 month 3
Extreme 3
3.24
Current year 2.96
Extreme 2.955
4.56
1 year 2.96
Extreme 2.955
4.95
3 years 2.96
Extreme 2.955
7.03
5 years 2.96
Extreme 2.955
9.28
10 years 2.96
Extreme 2.955
15.72
Manager TitleAgeSince
Chief Executive Officer 58 03/06/2025
Comptroller/Controller/Auditor 48 03/06/2025
Corporate Secretary 37 08/07/2026
Director TitleAgeSince
Director/Board Member 67 09/02/2011
Director/Board Member 69 11/06/2018
Director/Board Member 82 11/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+1.95%-34.66%-49.84% 503M
+3.92%+1.83%+49.01%+96.31% 1,040B
+1.87%-2.16%+32.50%+60.52% 599B
+3.87%+4.79%+24.10%+93.13% 485B
+4.17%+3.35%+74.23%+41.70% 350B
+3.09%+3.03%+29.59%+47.09% 345B
+2.82%+2.20%+17.90%+40.67% 272B
+3.40%+0.99%-3.44%+12.10% 244B
+3.24%+2.98%+44.76%+48.27% 223B
+3.64%+3.94%+28.82%+92.71% 183B
Average +3.15%+2.18%+26.28%+48.27% 374.33B
Weighted average by Cap. +3.35%+2.31%+36.77%+67.91%

Financials

2026 *2027 *
Net sales 6.98B 8.18B 1.04B 937M 875M 793M 1.49B 99.21B 1.5B 10.5B 4.1B 51.49B 3.91B 3.83B 166B 7.56B 8.86B 1.13B 1.02B 948M 859M 1.61B 107B 1.62B 11.37B 4.44B 55.78B 4.24B 4.15B 179B
Net income 454M 533M 67.86M 61.02M 56.94M 51.61M 96.89M 6.46B 97.49M 683M 267M 3.35B 255M 249M 10.78B 514M 602M 76.67M 68.94M 64.33M 58.31M 109M 7.3B 110M 772M 301M 3.79B 288M 282M 12.18B
Net Debt - -
Projected Income Statement - Annual - Tong Ren Tang Technologies Co. Ltd.
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change Volume
14/10/26 HK$3.130 +1.62% 1,516,000
13/10/26 HK$3.080 +0.82% 684,000
12/10/26 HK$3.055 +0.33% 327,000
09/10/26 HK$3.045 +0.16% 491,000
08/10/26 HK$3.040 -1.30% 577,000
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Tong Ren Tang Technologies Co. Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.671CNY
Average target price
4.601CNY
Spread / Average Target
+72.26%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tong Ren Tang Technologies Co. Ltd.
  1. Stock Market
  2. Stocks
  3. 1666 Stock